Vedana Therapeutics
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $46M
Investors
- 3
About Vedana Therapeutics
Vedana Therapeutics is engaged in the development of advanced biologic medicines for migraine relief. The company is headquartered in Seattle, US, and was founded by individuals with prior experience in the biotech sector.Vedana Therapeutics specializes in developing advanced biologic medicines aimed at providing migraine relief. Their core offerings include next-generation, long-acting therapeutics that enhance the efficacy of existing CGRP-targeted treatments and address PACAP and other CGRP-independent pathways.Vedana Therapeutics generates revenue through strategic partnerships and direct sales of its migraine therapies to healthcare providers and pharmacies. Their revenue model may include structured contracts that outline pricing and supply terms, potentially involving subscription models for ongoing therapeutic supply to clinics. The company is planning to launch new products designed specifically for migraine relief while expanding into new geographical markets. This includes targeting additional regions in North America and Europe, with an aim to enhance availability for patients by the end of 2027.
Who invested in Vedana Therapeutics
3 investors across 1 round
See all investors in Vedana Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 17, 2026
Amount
$46M
Investors
Questions about Vedana Therapeutics
Who invested in Vedana Therapeutics?
Vedana Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vedana Therapeutics raised?
Vedana Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vedana Therapeutics last raise money?
Vedana Therapeutics's most recent round on record is a Series A, in Jun 2026.
What does Vedana Therapeutics do?
Vedana Therapeutics is engaged in the development of advanced biologic medicines for migraine relief.
Where is Vedana Therapeutics headquartered?
Vedana Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Vedana Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vedana Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vedana Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.